C - REACTIVE PROTEIN AND ITS ASSOCIATION WITH SERUM URIC ACID AND BICARBONATE LEVEL IN COPD
- 15 September 2021
- journal article
- Published by World Wide Journals
Abstract
AIM: The study was planned to evaluate the association of C - reactive protein with Serum Uric Acid and Bicarbonate Level in COPD. MATERIAL AND METHODS: In the present study total 100 (n=100) patients diagnosed for COPD, were enrolled for the study. Patients with neoplastic pathologies, pneumonia and Liver or renal diseases, pregnant and lactating females were excluded from the study. RESULT: The mean level of Serum Bicarbonate, C-reactive protein and uric acid were signicantly higher in COPD patients. A signicant association was observed (p ≤ 0.0001). CONCLUSION: In the present study higher bicarbonate levels that could be the individual biomarker which can assess the respiratory acidosis and CRP and Uric Acid levels judges the severity the disease.Keywords
This publication has 10 references indexed in Scilit:
- Baseline C-Reactive Protein Level Predicts Survival of Early-Stage Lung Cancer: Evidence from a Systematic Review and Meta-AnalysisTumori Journal, 2016
- Clinical Significance of Symptoms in Smokers with Preserved Pulmonary FunctionThe New England Journal of Medicine, 2016
- Clinical and Radiologic Disease in Smokers With Normal SpirometryJAMA Internal Medicine, 2015
- Comparison between an Alternative and the Classic Definition of Chronic Bronchitis in COPDGeneAnnals of the American Thoracic Society, 2015
- Serum uric acid as a biomarker for prediction of outcomes of patients hospitalized for acute exacerbation of chronic obstructive pulmonary diseaseThe Egyptian Journal of Bronchology, 2014
- Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary DiseaseAmerican Journal of Respiratory and Critical Care Medicine, 2013
- The Relationship between Serum Uric Acid and Spirometric Values in Participants in a Health Check: The Takahata StudyInternational Journal of Medical Sciences, 2011
- Projections of Global Mortality and Burden of Disease from 2002 to 2030PLoS Medicine, 2006
- C-reactive protein in patients with COPD, control smokers and non-smokersThorax, 2005
- Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary DiseaseAmerican Journal of Respiratory and Critical Care Medicine, 2001